Revenue
2021
2022
2023
2024
2025
Immunocore Holdings plc (IMCR)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $400.0M | $310.2M | $249.4M | $174.4M | $4.1M |
| Research & development | $274.9M | $222.2M | $163.5M | $101.9M | $100.2M |
| Operating income | −$45.4M | −$70.5M | −$59.6M | −$51.7M | −$174.6M |
| EBITDAderived | −$42.3M | −$66.3M | −$55.5M | −$46.4M | −$167.0M |
| Net income | −$35.5M | −$51.1M | −$55.3M | −$52.5M | −$180.0M |
| Basic EPSper diluted share | -$0.71 | -$1.02 | -$1.13 | -$1.15 | -$4.24 |
| Diluted EPSper diluted share | -$0.71 | -$1.02 | -$1.13 | -$1.15 | -$4.24 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Feb 18, 2026Form 4 | St Leger Tina AmberCHIEF HR OFFICER | SellOrdinary Shares | 1.0K | $32.35 | $32.4K | 1.1K |
| Feb 18, 2026Form 4 | Berman David MHEAD OF R&D | SellOrdinary Shares | 6.0K | $32.35 | $193.0K | 5.9K |
| Feb 18, 2026Form 4 | GOLL JOHNSVP, FINANCE & CAO | SellOrdinary Shares | 698 | $32.35 | $22.6K | 653 |
| Feb 18, 2026Form 4 | Jallal BahijaCHIEF EXECUTIVE OFFICER | SellOrdinary Shares | 11.5K | $32.35 | $371.2K | 12.3K |
| Dec 5, 2025Form 4 · 10b5-1 | Berman David MHEAD OF R&D | SellOrdinary Shares | 572 | $40.14 | $23.0K | 0 |